Franklin Resources
GTBP icon

Franklin Resources’s GT Biopharma GTBP Stock Holding History

Franklin Resources’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-640
Closed -$57K – 2351
2022
Q2 		$57K Sell
640
-310
-33% -$23.5K ﹤0.01% 2225
2022
Q1 		$82K Hold
950
– – ﹤0.01% 2322
2021
Q4 		$87K Hold
950
– – ﹤0.01% 2358
2021
Q3 		$192K Buy
+950
New +$286K ﹤0.01% 2239

Other funds holding GTBP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $8.13B AUM 26.03% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Franklin Resources's GTBP Position: Q3 2022 in Review

Franklin Resources sold out of GT Biopharma (GTBP) in Q3 2022, closing a stake of 640 shares — an estimated $57K sold.

Franklin Resources first reported a position in GTBP in Q3 2021 and held it in 4 quarters. The position peaked at $192K in Q3 2021. 34 funds tracked by Wall St. Rank hold GTBP as of Q3 2022.

  • Franklin Resources reported no remaining GT Biopharma position as of Q3 2022 after selling out during the quarter.
  • Franklin Resources sold 640 GT Biopharma shares in Q3 2022, an estimated $57K.
  • Franklin Resources first reported a position in GT Biopharma in Q3 2021 and held it in 4 quarters.
  • Franklin Resources's GT Biopharma position peaked at $192K in Q3 2021.
  • 34 funds tracked by Wall St. Rank held GT Biopharma as of Q3 2022.

Based on Franklin Resources's 13F filing for Q3 2022, filed 14 Nov 2022.